Abstract
Bone is the most common site of metastatic disease associated with breast cancer (BC). Bisphosphonates inhibit osteoclast-mediated bone resorption, and novel targeted therapies such as denosumab, inhibit key pathways in the vicious cycle of bone metastases. To assess the effect of bisphosphonates on skeletal-related events (SREs), bone pain, quality of life (QoL), recurrence and survival in women with breast cancer with bone metastases (BCBM), advanced breast cancer (ABC) without clinical evidence of bone metastases and early breast cancer (EBC).To assess the effect of denosumab on SREs, bone pain and (QoL) in women with (BCBM). We searched the Specialised Register maintained by the Cochrane Breast Cancer Group (CBCGSR), MEDLINE, EMBASE and the WHO International Cancer Trials Registry Platform (WHO ICTRP) on 30 April 2011. We conducted additional handsearching of journals and proceedings of key meetings. We included randomised controlled trials (RCTs) comparing: (a) bisphosphonates and control, or different bisphosphonates in women with BCBM; (b) denosumab and bisphosphonates in women with BCBM; (c) bisphosphonates and control in women with ABC; (d) bisphosphonates and control in women with EBC; and (e) early versus delayed bis...Continue Reading
Citations
May 10, 2013·Cancer Metastasis Reviews·Boris Michael HolzapfelDietmar Werner Hutmacher
Aug 30, 2003·BMJ : British Medical Journal·J R RossS R D Johnston
Jan 1, 2014·Journal of Clinical Medicine·Bob T LiNick Pavlakis
Dec 9, 2015·Breast Cancer Research and Treatment·C JacobsM Clemons
Apr 5, 2016·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Arisa NishimukaiYasuo Miyoshi
Sep 14, 2016·International Journal of Molecular Sciences·Sandra CasimiroLuis Costa
May 12, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jan SchröderUNKNOWN TMK-Group (Tumour Registry Breast Cancer)
Jan 1, 2013·Journal of Clinical Medicine·Demetrios SimosMark Clemons
Jan 1, 2013·Journal of Clinical Medicine·Roger von Moos, Ian Haynes
Oct 31, 2017·The Cochrane Database of Systematic Reviews·Brent O'CarriganAnnabel Goodwin
Oct 28, 2015·Nature Reviews. Endocrinology·Issam MakhoulLarry J Suva
Feb 11, 2015·Breast Cancer Research and Treatment·Hongkai WangTongwei Chu
Dec 6, 2012·Pathology Oncology Research : POR·Orsolya Rusz, Zsuzsanna Kahán
Dec 27, 2017·The Cochrane Database of Systematic Reviews·Sascha MachereyNicole Skoetz
Dec 19, 2019·Cancer Medicine·Naoto T UenoBeth A Chasen
Jun 14, 2013·Paediatric Drugs·Cormac OwensAbha A Gupta
Jul 21, 2006·The Cochrane Database of Systematic Reviews·M J Martinez-ZapataE Català
Jan 22, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Laura MurphyScott Edwards
Jun 20, 2020·Cellular and Molecular Life Sciences : CMLS·Wenhui HuShiwu Dong
Aug 6, 2020·Cancers·Steven L Wood, Janet E Brown
Jul 17, 2020·Frontiers in Oncology·Anita J W M BrounsAnne-Marie C Dingemans
Dec 30, 2017·Experimental and Therapeutic Medicine·Runying ZouXiangling He
Oct 13, 2020·Frontiers in Oncology·Francesco MannavolaMarco Tucci
Nov 17, 2020·Frontiers in Oncology·Anita J W M BrounsLizza E L Hendriks
Mar 7, 2021·Bone·S D'Oronzo-J E Brown-
May 1, 2021·International Journal of Environmental Research and Public Health·Antonio Jose Martin-PerezMario Lozano-Lozano
Aug 19, 2021·The Journal of Nutritional Biochemistry·Andrew G KunihiroJanet L Funk
Aug 26, 2020·Current Drug Research Reviews·Jubie SelvarajNeetu Yadav